nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—EGFR—asthma	0.378	1	CbGaD
Afatinib—ABCG2—Zafirlukast—asthma	0.0537	0.252	CbGbCtD
Afatinib—ABCB1—Fluticasone furoate—asthma	0.0326	0.153	CbGbCtD
Afatinib—ABCB1—Indacaterol—asthma	0.0266	0.125	CbGbCtD
Afatinib—ABCG2—Hydrocortisone—asthma	0.0219	0.103	CbGbCtD
Afatinib—ABCB1—Loratadine—asthma	0.0142	0.0666	CbGbCtD
Afatinib—ABCG2—Dexamethasone—asthma	0.0136	0.0639	CbGbCtD
Afatinib—ABCB1—Methylprednisolone—asthma	0.013	0.0609	CbGbCtD
Afatinib—ABCB1—Betamethasone—asthma	0.00843	0.0396	CbGbCtD
Afatinib—ABCB1—Prednisolone—asthma	0.00832	0.0391	CbGbCtD
Afatinib—ABCB1—Hydrocortisone—asthma	0.00789	0.037	CbGbCtD
Afatinib—ABCB1—Prednisone—asthma	0.00786	0.0369	CbGbCtD
Afatinib—ERBB2—exocrine gland—asthma	0.00505	0.0824	CbGeAlD
Afatinib—ABCB1—Dexamethasone—asthma	0.0049	0.023	CbGbCtD
Afatinib—ERBB4—respiratory system—asthma	0.00263	0.0429	CbGeAlD
Afatinib—ERBB2—respiratory system—asthma	0.00263	0.0429	CbGeAlD
Afatinib—DYRK1A—respiratory system—asthma	0.00253	0.0413	CbGeAlD
Afatinib—BLK—adrenal gland—asthma	0.00232	0.0379	CbGeAlD
Afatinib—ERBB2—epithelium—asthma	0.0022	0.0358	CbGeAlD
Afatinib—ERBB4—epithelium—asthma	0.0022	0.0358	CbGeAlD
Afatinib—ERBB2—smooth muscle tissue—asthma	0.00212	0.0345	CbGeAlD
Afatinib—ERBB4—cardiovascular system—asthma	0.00201	0.0329	CbGeAlD
Afatinib—ERBB2—cardiovascular system—asthma	0.00201	0.0329	CbGeAlD
Afatinib—DYRK1A—cardiovascular system—asthma	0.00194	0.0316	CbGeAlD
Afatinib—PHKG2—adrenal gland—asthma	0.00177	0.0289	CbGeAlD
Afatinib—IRAK1—bronchus—asthma	0.00162	0.0264	CbGeAlD
Afatinib—ERBB2—adrenal gland—asthma	0.00159	0.026	CbGeAlD
Afatinib—IRAK1—smooth muscle tissue—asthma	0.00158	0.0258	CbGeAlD
Afatinib—LCK—bronchus—asthma	0.00158	0.0258	CbGeAlD
Afatinib—PHKG2—lung—asthma	0.00155	0.0253	CbGeAlD
Afatinib—DYRK1A—adrenal gland—asthma	0.00153	0.025	CbGeAlD
Afatinib—LCK—trachea—asthma	0.00142	0.0231	CbGeAlD
Afatinib—ERBB2—Theophylline—Aminophylline—asthma	0.00142	0.253	CbGdCrCtD
Afatinib—ERBB2—lung—asthma	0.0014	0.0228	CbGeAlD
Afatinib—ERBB4—lung—asthma	0.0014	0.0228	CbGeAlD
Afatinib—EGFR—adrenal gland—asthma	0.00135	0.022	CbGeAlD
Afatinib—DYRK1A—lung—asthma	0.00134	0.0219	CbGeAlD
Afatinib—IRAK1—adrenal gland—asthma	0.00119	0.0194	CbGeAlD
Afatinib—EGFR—lung—asthma	0.00118	0.0193	CbGeAlD
Afatinib—LCK—adrenal gland—asthma	0.00116	0.019	CbGeAlD
Afatinib—ABL1—respiratory system—asthma	0.0011	0.018	CbGeAlD
Afatinib—IRAK1—lung—asthma	0.00104	0.017	CbGeAlD
Afatinib—LCK—lung—asthma	0.00102	0.0166	CbGeAlD
Afatinib—Vandetanib—VEGFA—asthma	0.00101	0.315	CrCbGaD
Afatinib—ABL1—adrenal cortex—asthma	0.000924	0.0151	CbGeAlD
Afatinib—ERBB2—Theophylline—Dyphylline—asthma	0.000913	0.163	CbGdCrCtD
Afatinib—ABL1—bronchus—asthma	0.000906	0.0148	CbGeAlD
Afatinib—ABL1—smooth muscle tissue—asthma	0.000887	0.0145	CbGeAlD
Afatinib—Vandetanib—EGFR—asthma	0.000848	0.266	CrCbGaD
Afatinib—ABL1—cardiovascular system—asthma	0.000844	0.0138	CbGeAlD
Afatinib—ABL1—trachea—asthma	0.000814	0.0133	CbGeAlD
Afatinib—Gefitinib—EGFR—asthma	0.000806	0.253	CrCbGaD
Afatinib—ABL1—adrenal gland—asthma	0.000667	0.0109	CbGeAlD
Afatinib—ABL1—lung—asthma	0.000585	0.00954	CbGeAlD
Afatinib—ABCG2—adrenal cortex—asthma	0.000583	0.00951	CbGeAlD
Afatinib—ERBB2—Formoterol—Arformoterol—asthma	0.00052	0.0928	CbGdCrCtD
Afatinib—ERBB2—Arformoterol—Formoterol—asthma	0.00052	0.0928	CbGdCrCtD
Afatinib—ERBB2—Formoterol—Isoprenaline—asthma	0.000434	0.0775	CbGdCrCtD
Afatinib—ERBB2—Arformoterol—Isoprenaline—asthma	0.000434	0.0775	CbGdCrCtD
Afatinib—ABCG2—adrenal gland—asthma	0.000421	0.00687	CbGeAlD
Afatinib—ABCG2—lung—asthma	0.000369	0.00602	CbGeAlD
Afatinib—ABCB1—respiratory system—asthma	0.000342	0.00559	CbGeAlD
Afatinib—ABCB1—adrenal cortex—asthma	0.000287	0.00469	CbGeAlD
Afatinib—ABCB1—epithelium—asthma	0.000286	0.00467	CbGeAlD
Afatinib—Vandetanib—ALB—asthma	0.00027	0.0848	CrCbGaD
Afatinib—ABCB1—cardiovascular system—asthma	0.000262	0.00428	CbGeAlD
Afatinib—Gefitinib—ALB—asthma	0.000257	0.0806	CrCbGaD
Afatinib—ABCB1—trachea—asthma	0.000253	0.00413	CbGeAlD
Afatinib—ABCB1—adrenal gland—asthma	0.000207	0.00339	CbGeAlD
Afatinib—ABCB1—lung—asthma	0.000182	0.00297	CbGeAlD
Afatinib—Dry skin—Dexamethasone—asthma	0.000124	0.000686	CcSEcCtD
Afatinib—Dry skin—Betamethasone—asthma	0.000124	0.000686	CcSEcCtD
Afatinib—Body temperature increased—Mometasone—asthma	0.000124	0.000685	CcSEcCtD
Afatinib—Dyspnoea—Salbutamol—asthma	0.000124	0.000685	CcSEcCtD
Afatinib—Weight decreased—Hydrocortisone—asthma	0.000124	0.000685	CcSEcCtD
Afatinib—Hypokalaemia—Betamethasone—asthma	0.000124	0.000681	CcSEcCtD
Afatinib—Hypokalaemia—Dexamethasone—asthma	0.000124	0.000681	CcSEcCtD
Afatinib—Vomiting—Aminophylline—asthma	0.000123	0.00068	CcSEcCtD
Afatinib—Dyspepsia—Salbutamol—asthma	0.000123	0.000676	CcSEcCtD
Afatinib—Infestation NOS—Hydrocortisone—asthma	0.000123	0.000675	CcSEcCtD
Afatinib—Infestation—Hydrocortisone—asthma	0.000123	0.000675	CcSEcCtD
Afatinib—Rash—Aminophylline—asthma	0.000122	0.000674	CcSEcCtD
Afatinib—Dermatitis—Aminophylline—asthma	0.000122	0.000673	CcSEcCtD
Afatinib—Insomnia—Budesonide—asthma	0.000122	0.000673	CcSEcCtD
Afatinib—Conjunctivitis—Prednisolone—asthma	0.000122	0.000671	CcSEcCtD
Afatinib—Asthenia—Flunisolide—asthma	0.000122	0.00067	CcSEcCtD
Afatinib—Nausea—Fluticasone Propionate—asthma	0.000122	0.00067	CcSEcCtD
Afatinib—Headache—Aminophylline—asthma	0.000122	0.00067	CcSEcCtD
Afatinib—Nausea—Salmeterol—asthma	0.000121	0.000669	CcSEcCtD
Afatinib—Dizziness—Loratadine—asthma	0.000121	0.000668	CcSEcCtD
Afatinib—Decreased appetite—Salbutamol—asthma	0.000121	0.000668	CcSEcCtD
Afatinib—Dizziness—Tiotropium—asthma	0.000121	0.000667	CcSEcCtD
Afatinib—Dyspnoea—Budesonide—asthma	0.00012	0.000663	CcSEcCtD
Afatinib—Gastrointestinal disorder—Salbutamol—asthma	0.00012	0.000663	CcSEcCtD
Afatinib—Fatigue—Salbutamol—asthma	0.00012	0.000662	CcSEcCtD
Afatinib—Upper respiratory tract infection—Triamcinolone—asthma	0.00012	0.000662	CcSEcCtD
Afatinib—Pruritus—Flunisolide—asthma	0.00012	0.000661	CcSEcCtD
Afatinib—Constipation—Salbutamol—asthma	0.000119	0.000657	CcSEcCtD
Afatinib—Dyspepsia—Budesonide—asthma	0.000119	0.000655	CcSEcCtD
Afatinib—Decreased appetite—Budesonide—asthma	0.000117	0.000647	CcSEcCtD
Afatinib—Body temperature increased—Arformoterol—asthma	0.000117	0.000643	CcSEcCtD
Afatinib—Body temperature increased—Formoterol—asthma	0.000117	0.000643	CcSEcCtD
Afatinib—Gastrointestinal disorder—Budesonide—asthma	0.000117	0.000642	CcSEcCtD
Afatinib—Vomiting—Loratadine—asthma	0.000117	0.000642	CcSEcCtD
Afatinib—Fatigue—Budesonide—asthma	0.000116	0.000641	CcSEcCtD
Afatinib—Vomiting—Tiotropium—asthma	0.000116	0.000641	CcSEcCtD
Afatinib—Diarrhoea—Flunisolide—asthma	0.000116	0.000639	CcSEcCtD
Afatinib—Rash—Loratadine—asthma	0.000116	0.000637	CcSEcCtD
Afatinib—Constipation—Budesonide—asthma	0.000116	0.000636	CcSEcCtD
Afatinib—Dermatitis—Loratadine—asthma	0.000116	0.000636	CcSEcCtD
Afatinib—Rash—Tiotropium—asthma	0.000115	0.000636	CcSEcCtD
Afatinib—Dermatitis—Tiotropium—asthma	0.000115	0.000635	CcSEcCtD
Afatinib—Nausea—Aminophylline—asthma	0.000115	0.000635	CcSEcCtD
Afatinib—Infestation NOS—Methylprednisolone—asthma	0.000115	0.000634	CcSEcCtD
Afatinib—Infestation—Methylprednisolone—asthma	0.000115	0.000634	CcSEcCtD
Afatinib—Headache—Loratadine—asthma	0.000115	0.000633	CcSEcCtD
Afatinib—Headache—Tiotropium—asthma	0.000115	0.000631	CcSEcCtD
Afatinib—Body temperature increased—Montelukast—asthma	0.000114	0.00063	CcSEcCtD
Afatinib—Asthenia—Mometasone—asthma	0.000113	0.000622	CcSEcCtD
Afatinib—Dizziness—Flunisolide—asthma	0.000112	0.000618	CcSEcCtD
Afatinib—Conjunctivitis—Triamcinolone—asthma	0.000112	0.000617	CcSEcCtD
Afatinib—Pruritus—Mometasone—asthma	0.000111	0.000613	CcSEcCtD
Afatinib—Body temperature increased—Salbutamol—asthma	0.00011	0.000607	CcSEcCtD
Afatinib—Nausea—Loratadine—asthma	0.000109	0.0006	CcSEcCtD
Afatinib—Epistaxis—Triamcinolone—asthma	0.000109	0.000599	CcSEcCtD
Afatinib—Nausea—Tiotropium—asthma	0.000109	0.000599	CcSEcCtD
Afatinib—Dry skin—Prednisone—asthma	0.000108	0.000597	CcSEcCtD
Afatinib—Connective tissue disorder—Hydrocortisone—asthma	0.000108	0.000595	CcSEcCtD
Afatinib—Vomiting—Flunisolide—asthma	0.000108	0.000594	CcSEcCtD
Afatinib—Diarrhoea—Mometasone—asthma	0.000108	0.000593	CcSEcCtD
Afatinib—Hypokalaemia—Prednisone—asthma	0.000108	0.000593	CcSEcCtD
Afatinib—Rash—Flunisolide—asthma	0.000107	0.000589	CcSEcCtD
Afatinib—Dermatitis—Flunisolide—asthma	0.000107	0.000589	CcSEcCtD
Afatinib—Body temperature increased—Budesonide—asthma	0.000107	0.000588	CcSEcCtD
Afatinib—Headache—Flunisolide—asthma	0.000106	0.000585	CcSEcCtD
Afatinib—Weight decreased—Betamethasone—asthma	0.000106	0.000585	CcSEcCtD
Afatinib—Weight decreased—Dexamethasone—asthma	0.000106	0.000585	CcSEcCtD
Afatinib—Asthenia—Arformoterol—asthma	0.000106	0.000584	CcSEcCtD
Afatinib—Asthenia—Formoterol—asthma	0.000106	0.000584	CcSEcCtD
Afatinib—Pruritus—Formoterol—asthma	0.000105	0.000576	CcSEcCtD
Afatinib—Pruritus—Arformoterol—asthma	0.000105	0.000576	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Prednisone—asthma	0.000104	0.000574	CcSEcCtD
Afatinib—Asthenia—Montelukast—asthma	0.000104	0.000572	CcSEcCtD
Afatinib—Eye disorder—Hydrocortisone—asthma	0.000103	0.000566	CcSEcCtD
Afatinib—Pruritus—Montelukast—asthma	0.000102	0.000564	CcSEcCtD
Afatinib—Conjunctivitis—Dexamethasone—asthma	0.000102	0.00056	CcSEcCtD
Afatinib—Conjunctivitis—Betamethasone—asthma	0.000102	0.00056	CcSEcCtD
Afatinib—Connective tissue disorder—Methylprednisolone—asthma	0.000102	0.000559	CcSEcCtD
Afatinib—Diarrhoea—Arformoterol—asthma	0.000101	0.000557	CcSEcCtD
Afatinib—Diarrhoea—Formoterol—asthma	0.000101	0.000557	CcSEcCtD
Afatinib—Nausea—Flunisolide—asthma	0.000101	0.000555	CcSEcCtD
Afatinib—Asthenia—Salbutamol—asthma	0.0001	0.000551	CcSEcCtD
Afatinib—Vomiting—Mometasone—asthma	0.0001	0.000551	CcSEcCtD
Afatinib—Rash—Mometasone—asthma	9.92e-05	0.000546	CcSEcCtD
Afatinib—Dermatitis—Mometasone—asthma	9.91e-05	0.000546	CcSEcCtD
Afatinib—Diarrhoea—Montelukast—asthma	9.9e-05	0.000545	CcSEcCtD
Afatinib—Pruritus—Salbutamol—asthma	9.87e-05	0.000543	CcSEcCtD
Afatinib—Headache—Mometasone—asthma	9.86e-05	0.000543	CcSEcCtD
Afatinib—Dizziness—Formoterol—asthma	9.77e-05	0.000538	CcSEcCtD
Afatinib—Dizziness—Arformoterol—asthma	9.77e-05	0.000538	CcSEcCtD
Afatinib—Asthenia—Budesonide—asthma	9.69e-05	0.000534	CcSEcCtD
Afatinib—Eye disorder—Methylprednisolone—asthma	9.66e-05	0.000532	CcSEcCtD
Afatinib—Mental disorder—Hydrocortisone—asthma	9.63e-05	0.000531	CcSEcCtD
Afatinib—Malnutrition—Hydrocortisone—asthma	9.57e-05	0.000527	CcSEcCtD
Afatinib—Dizziness—Montelukast—asthma	9.57e-05	0.000527	CcSEcCtD
Afatinib—Pruritus—Budesonide—asthma	9.56e-05	0.000526	CcSEcCtD
Afatinib—Diarrhoea—Salbutamol—asthma	9.54e-05	0.000526	CcSEcCtD
Afatinib—ERBB2—Triamcinolone—Fluticasone furoate—asthma	9.48e-05	0.0169	CbGdCrCtD
Afatinib—Vomiting—Arformoterol—asthma	9.39e-05	0.000517	CcSEcCtD
Afatinib—Vomiting—Formoterol—asthma	9.39e-05	0.000517	CcSEcCtD
Afatinib—Nausea—Mometasone—asthma	9.35e-05	0.000515	CcSEcCtD
Afatinib—Rash—Formoterol—asthma	9.31e-05	0.000513	CcSEcCtD
Afatinib—Rash—Arformoterol—asthma	9.31e-05	0.000513	CcSEcCtD
Afatinib—Mediastinal disorder—Methylprednisolone—asthma	9.31e-05	0.000513	CcSEcCtD
Afatinib—Dermatitis—Arformoterol—asthma	9.31e-05	0.000512	CcSEcCtD
Afatinib—Dermatitis—Formoterol—asthma	9.31e-05	0.000512	CcSEcCtD
Afatinib—Headache—Arformoterol—asthma	9.25e-05	0.00051	CcSEcCtD
Afatinib—Headache—Formoterol—asthma	9.25e-05	0.00051	CcSEcCtD
Afatinib—Weight decreased—Prednisone—asthma	9.25e-05	0.000509	CcSEcCtD
Afatinib—Diarrhoea—Budesonide—asthma	9.24e-05	0.000509	CcSEcCtD
Afatinib—Dizziness—Salbutamol—asthma	9.22e-05	0.000508	CcSEcCtD
Afatinib—Vomiting—Montelukast—asthma	9.2e-05	0.000507	CcSEcCtD
Afatinib—Rash—Montelukast—asthma	9.12e-05	0.000502	CcSEcCtD
Afatinib—Dermatitis—Montelukast—asthma	9.11e-05	0.000502	CcSEcCtD
Afatinib—Headache—Montelukast—asthma	9.06e-05	0.000499	CcSEcCtD
Afatinib—Mental disorder—Methylprednisolone—asthma	9.05e-05	0.000499	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Fluticasone furoate—asthma	9.01e-05	0.0161	CbGdCrCtD
Afatinib—Malnutrition—Methylprednisolone—asthma	8.99e-05	0.000495	CcSEcCtD
Afatinib—Dizziness—Budesonide—asthma	8.93e-05	0.000492	CcSEcCtD
Afatinib—Vomiting—Salbutamol—asthma	8.87e-05	0.000488	CcSEcCtD
Afatinib—ERBB2—Triamcinolone—Fluticasone Propionate—asthma	8.85e-05	0.0158	CbGdCrCtD
Afatinib—Dysgeusia—Triamcinolone—asthma	8.83e-05	0.000486	CcSEcCtD
Afatinib—Rash—Salbutamol—asthma	8.79e-05	0.000484	CcSEcCtD
Afatinib—Dermatitis—Salbutamol—asthma	8.79e-05	0.000484	CcSEcCtD
Afatinib—Eye disorder—Dexamethasone—asthma	8.78e-05	0.000484	CcSEcCtD
Afatinib—Eye disorder—Betamethasone—asthma	8.78e-05	0.000484	CcSEcCtD
Afatinib—Nausea—Arformoterol—asthma	8.77e-05	0.000483	CcSEcCtD
Afatinib—Nausea—Formoterol—asthma	8.77e-05	0.000483	CcSEcCtD
Afatinib—Headache—Salbutamol—asthma	8.74e-05	0.000481	CcSEcCtD
Afatinib—Back pain—Triamcinolone—asthma	8.72e-05	0.00048	CcSEcCtD
Afatinib—Nausea—Montelukast—asthma	8.59e-05	0.000473	CcSEcCtD
Afatinib—Vomiting—Budesonide—asthma	8.59e-05	0.000473	CcSEcCtD
Afatinib—Rash—Budesonide—asthma	8.52e-05	0.000469	CcSEcCtD
Afatinib—Dermatitis—Budesonide—asthma	8.51e-05	0.000469	CcSEcCtD
Afatinib—Headache—Budesonide—asthma	8.46e-05	0.000466	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Fluticasone Propionate—asthma	8.4e-05	0.015	CbGdCrCtD
Afatinib—Alopecia—Betamethasone—asthma	8.3e-05	0.000457	CcSEcCtD
Afatinib—Alopecia—Dexamethasone—asthma	8.3e-05	0.000457	CcSEcCtD
Afatinib—Nausea—Salbutamol—asthma	8.28e-05	0.000456	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	8.09e-05	0.000446	CcSEcCtD
Afatinib—Connective tissue disorder—Prednisone—asthma	8.04e-05	0.000443	CcSEcCtD
Afatinib—Nausea—Budesonide—asthma	8.03e-05	0.000442	CcSEcCtD
Afatinib—Cough—Triamcinolone—asthma	7.87e-05	0.000433	CcSEcCtD
Afatinib—Infection—Hydrocortisone—asthma	7.76e-05	0.000427	CcSEcCtD
Afatinib—Nervous system disorder—Hydrocortisone—asthma	7.66e-05	0.000422	CcSEcCtD
Afatinib—Eye disorder—Prednisone—asthma	7.65e-05	0.000421	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	7.6e-05	0.000419	CcSEcCtD
Afatinib—Skin disorder—Hydrocortisone—asthma	7.59e-05	0.000418	CcSEcCtD
Afatinib—Infection—Triamcinolone—asthma	7.31e-05	0.000403	CcSEcCtD
Afatinib—Infection—Methylprednisolone—asthma	7.29e-05	0.000402	CcSEcCtD
Afatinib—Insomnia—Prednisolone—asthma	7.24e-05	0.000398	CcSEcCtD
Afatinib—Alopecia—Prednisone—asthma	7.23e-05	0.000398	CcSEcCtD
Afatinib—Nervous system disorder—Methylprednisolone—asthma	7.2e-05	0.000396	CcSEcCtD
Afatinib—Mental disorder—Prednisone—asthma	7.17e-05	0.000395	CcSEcCtD
Afatinib—Skin disorder—Methylprednisolone—asthma	7.13e-05	0.000393	CcSEcCtD
Afatinib—Malnutrition—Prednisone—asthma	7.12e-05	0.000392	CcSEcCtD
Afatinib—Insomnia—Hydrocortisone—asthma	7.07e-05	0.000389	CcSEcCtD
Afatinib—Dyspepsia—Hydrocortisone—asthma	6.88e-05	0.000379	CcSEcCtD
Afatinib—Decreased appetite—Hydrocortisone—asthma	6.79e-05	0.000374	CcSEcCtD
Afatinib—Gastrointestinal disorder—Hydrocortisone—asthma	6.75e-05	0.000371	CcSEcCtD
Afatinib—Fatigue—Hydrocortisone—asthma	6.74e-05	0.000371	CcSEcCtD
Afatinib—Insomnia—Triamcinolone—asthma	6.65e-05	0.000366	CcSEcCtD
Afatinib—Insomnia—Methylprednisolone—asthma	6.64e-05	0.000366	CcSEcCtD
Afatinib—Infection—Betamethasone—asthma	6.63e-05	0.000365	CcSEcCtD
Afatinib—Infection—Dexamethasone—asthma	6.63e-05	0.000365	CcSEcCtD
Afatinib—Dyspnoea—Triamcinolone—asthma	6.56e-05	0.000361	CcSEcCtD
Afatinib—Nervous system disorder—Betamethasone—asthma	6.55e-05	0.000361	CcSEcCtD
Afatinib—Nervous system disorder—Dexamethasone—asthma	6.55e-05	0.000361	CcSEcCtD
Afatinib—ERBB2—Triamcinolone—Beclomethasone—asthma	6.5e-05	0.0116	CbGdCrCtD
Afatinib—Dyspepsia—Triamcinolone—asthma	6.48e-05	0.000357	CcSEcCtD
Afatinib—Dyspepsia—Methylprednisolone—asthma	6.46e-05	0.000356	CcSEcCtD
Afatinib—Fatigue—Triamcinolone—asthma	6.34e-05	0.000349	CcSEcCtD
Afatinib—Fatigue—Methylprednisolone—asthma	6.33e-05	0.000349	CcSEcCtD
Afatinib—ERBB2—Triamcinolone—Budesonide—asthma	6.23e-05	0.0111	CbGdCrCtD
Afatinib—Body temperature increased—Hydrocortisone—asthma	6.18e-05	0.00034	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Beclomethasone—asthma	6.17e-05	0.011	CbGdCrCtD
Afatinib—ERBB2—Triamcinolone—Flunisolide—asthma	6.15e-05	0.011	CbGdCrCtD
Afatinib—Insomnia—Dexamethasone—asthma	6.04e-05	0.000332	CcSEcCtD
Afatinib—Insomnia—Betamethasone—asthma	6.04e-05	0.000332	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	6.02e-05	0.000332	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Budesonide—asthma	5.92e-05	0.0106	CbGdCrCtD
Afatinib—Dyspepsia—Betamethasone—asthma	5.88e-05	0.000324	CcSEcCtD
Afatinib—Dyspepsia—Dexamethasone—asthma	5.88e-05	0.000324	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Flunisolide—asthma	5.84e-05	0.0104	CbGdCrCtD
Afatinib—Body temperature increased—Triamcinolone—asthma	5.82e-05	0.00032	CcSEcCtD
Afatinib—Decreased appetite—Betamethasone—asthma	5.8e-05	0.00032	CcSEcCtD
Afatinib—Decreased appetite—Dexamethasone—asthma	5.8e-05	0.00032	CcSEcCtD
Afatinib—Infection—Prednisone—asthma	5.78e-05	0.000318	CcSEcCtD
Afatinib—Gastrointestinal disorder—Betamethasone—asthma	5.76e-05	0.000317	CcSEcCtD
Afatinib—Gastrointestinal disorder—Dexamethasone—asthma	5.76e-05	0.000317	CcSEcCtD
Afatinib—Fatigue—Dexamethasone—asthma	5.76e-05	0.000317	CcSEcCtD
Afatinib—Fatigue—Betamethasone—asthma	5.76e-05	0.000317	CcSEcCtD
Afatinib—Nervous system disorder—Prednisone—asthma	5.7e-05	0.000314	CcSEcCtD
Afatinib—Skin disorder—Prednisone—asthma	5.65e-05	0.000311	CcSEcCtD
Afatinib—Asthenia—Hydrocortisone—asthma	5.61e-05	0.000309	CcSEcCtD
Afatinib—Pruritus—Hydrocortisone—asthma	5.53e-05	0.000304	CcSEcCtD
Afatinib—ERBB2—Exemestane—Methylprednisolone—asthma	5.53e-05	0.00986	CbGdCrCtD
Afatinib—Diarrhoea—Hydrocortisone—asthma	5.35e-05	0.000294	CcSEcCtD
Afatinib—Dizziness—Prednisolone—asthma	5.29e-05	0.000291	CcSEcCtD
Afatinib—Asthenia—Triamcinolone—asthma	5.28e-05	0.000291	CcSEcCtD
Afatinib—Body temperature increased—Dexamethasone—asthma	5.28e-05	0.000291	CcSEcCtD
Afatinib—Body temperature increased—Betamethasone—asthma	5.28e-05	0.000291	CcSEcCtD
Afatinib—Asthenia—Methylprednisolone—asthma	5.27e-05	0.00029	CcSEcCtD
Afatinib—Insomnia—Prednisone—asthma	5.26e-05	0.00029	CcSEcCtD
Afatinib—Pruritus—Triamcinolone—asthma	5.2e-05	0.000287	CcSEcCtD
Afatinib—Pruritus—Methylprednisolone—asthma	5.19e-05	0.000286	CcSEcCtD
Afatinib—Dizziness—Hydrocortisone—asthma	5.17e-05	0.000285	CcSEcCtD
Afatinib—Dyspepsia—Prednisone—asthma	5.12e-05	0.000282	CcSEcCtD
Afatinib—Decreased appetite—Prednisone—asthma	5.05e-05	0.000278	CcSEcCtD
Afatinib—Rash—Prednisolone—asthma	5.04e-05	0.000278	CcSEcCtD
Afatinib—ERBB2—Exemestane—Prednisone—asthma	5.04e-05	0.009	CbGdCrCtD
Afatinib—ERBB2—Triamcinolone—Mometasone—asthma	5.04e-05	0.00899	CbGdCrCtD
Afatinib—Dermatitis—Prednisolone—asthma	5.04e-05	0.000278	CcSEcCtD
Afatinib—Diarrhoea—Methylprednisolone—asthma	5.02e-05	0.000277	CcSEcCtD
Afatinib—Fatigue—Prednisone—asthma	5.01e-05	0.000276	CcSEcCtD
Afatinib—Headache—Prednisolone—asthma	5.01e-05	0.000276	CcSEcCtD
Afatinib—Constipation—Prednisone—asthma	4.97e-05	0.000274	CcSEcCtD
Afatinib—Vomiting—Hydrocortisone—asthma	4.97e-05	0.000274	CcSEcCtD
Afatinib—Rash—Hydrocortisone—asthma	4.93e-05	0.000271	CcSEcCtD
Afatinib—ERBB2—Exemestane—Prednisolone—asthma	4.92e-05	0.00878	CbGdCrCtD
Afatinib—Dermatitis—Hydrocortisone—asthma	4.92e-05	0.000271	CcSEcCtD
Afatinib—Headache—Hydrocortisone—asthma	4.89e-05	0.00027	CcSEcCtD
Afatinib—Dizziness—Triamcinolone—asthma	4.86e-05	0.000268	CcSEcCtD
Afatinib—Dizziness—Methylprednisolone—asthma	4.85e-05	0.000267	CcSEcCtD
Afatinib—Asthenia—Dexamethasone—asthma	4.79e-05	0.000264	CcSEcCtD
Afatinib—Asthenia—Betamethasone—asthma	4.79e-05	0.000264	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Mometasone—asthma	4.79e-05	0.00854	CbGdCrCtD
Afatinib—Nausea—Prednisolone—asthma	4.75e-05	0.000262	CcSEcCtD
Afatinib—Pruritus—Dexamethasone—asthma	4.72e-05	0.00026	CcSEcCtD
Afatinib—Pruritus—Betamethasone—asthma	4.72e-05	0.00026	CcSEcCtD
Afatinib—Vomiting—Triamcinolone—asthma	4.68e-05	0.000258	CcSEcCtD
Afatinib—Vomiting—Methylprednisolone—asthma	4.67e-05	0.000257	CcSEcCtD
Afatinib—Nausea—Hydrocortisone—asthma	4.64e-05	0.000256	CcSEcCtD
Afatinib—Rash—Triamcinolone—asthma	4.64e-05	0.000255	CcSEcCtD
Afatinib—Dermatitis—Triamcinolone—asthma	4.63e-05	0.000255	CcSEcCtD
Afatinib—Rash—Methylprednisolone—asthma	4.63e-05	0.000255	CcSEcCtD
Afatinib—Dermatitis—Methylprednisolone—asthma	4.62e-05	0.000255	CcSEcCtD
Afatinib—Headache—Triamcinolone—asthma	4.61e-05	0.000254	CcSEcCtD
Afatinib—Headache—Methylprednisolone—asthma	4.6e-05	0.000253	CcSEcCtD
Afatinib—Body temperature increased—Prednisone—asthma	4.6e-05	0.000253	CcSEcCtD
Afatinib—Diarrhoea—Betamethasone—asthma	4.57e-05	0.000252	CcSEcCtD
Afatinib—Diarrhoea—Dexamethasone—asthma	4.57e-05	0.000252	CcSEcCtD
Afatinib—Dizziness—Dexamethasone—asthma	4.41e-05	0.000243	CcSEcCtD
Afatinib—Dizziness—Betamethasone—asthma	4.41e-05	0.000243	CcSEcCtD
Afatinib—Nausea—Triamcinolone—asthma	4.37e-05	0.000241	CcSEcCtD
Afatinib—Nausea—Methylprednisolone—asthma	4.36e-05	0.00024	CcSEcCtD
Afatinib—Vomiting—Dexamethasone—asthma	4.24e-05	0.000234	CcSEcCtD
Afatinib—Vomiting—Betamethasone—asthma	4.24e-05	0.000234	CcSEcCtD
Afatinib—Rash—Dexamethasone—asthma	4.21e-05	0.000232	CcSEcCtD
Afatinib—Rash—Betamethasone—asthma	4.21e-05	0.000232	CcSEcCtD
Afatinib—Dermatitis—Dexamethasone—asthma	4.21e-05	0.000232	CcSEcCtD
Afatinib—Dermatitis—Betamethasone—asthma	4.21e-05	0.000232	CcSEcCtD
Afatinib—Headache—Betamethasone—asthma	4.18e-05	0.00023	CcSEcCtD
Afatinib—Headache—Dexamethasone—asthma	4.18e-05	0.00023	CcSEcCtD
Afatinib—Asthenia—Prednisone—asthma	4.17e-05	0.00023	CcSEcCtD
Afatinib—Pruritus—Prednisone—asthma	4.11e-05	0.000227	CcSEcCtD
Afatinib—Diarrhoea—Prednisone—asthma	3.98e-05	0.000219	CcSEcCtD
Afatinib—Nausea—Betamethasone—asthma	3.97e-05	0.000218	CcSEcCtD
Afatinib—Nausea—Dexamethasone—asthma	3.97e-05	0.000218	CcSEcCtD
Afatinib—Dizziness—Prednisone—asthma	3.84e-05	0.000212	CcSEcCtD
Afatinib—Vomiting—Prednisone—asthma	3.7e-05	0.000204	CcSEcCtD
Afatinib—Rash—Prednisone—asthma	3.67e-05	0.000202	CcSEcCtD
Afatinib—Dermatitis—Prednisone—asthma	3.66e-05	0.000202	CcSEcCtD
Afatinib—Headache—Prednisone—asthma	3.64e-05	0.000201	CcSEcCtD
Afatinib—Nausea—Prednisone—asthma	3.45e-05	0.00019	CcSEcCtD
Afatinib—ERBB2—Triamcinolone—Hydrocortisone—asthma	3.19e-05	0.00569	CbGdCrCtD
Afatinib—ERBB2—Desoximetasone—Hydrocortisone—asthma	3.03e-05	0.00541	CbGdCrCtD
Afatinib—ERBB2—Triamcinolone—Methylprednisolone—asthma	3.01e-05	0.00537	CbGdCrCtD
Afatinib—ERBB2—Triamcinolone—Betamethasone—asthma	2.96e-05	0.00529	CbGdCrCtD
Afatinib—ERBB2—Triamcinolone—Dexamethasone—asthma	2.96e-05	0.00529	CbGdCrCtD
Afatinib—ERBB2—Desoximetasone—Methylprednisolone—asthma	2.86e-05	0.0051	CbGdCrCtD
Afatinib—ERBB2—Desoximetasone—Betamethasone—asthma	2.81e-05	0.00502	CbGdCrCtD
Afatinib—ERBB2—Desoximetasone—Dexamethasone—asthma	2.81e-05	0.00502	CbGdCrCtD
Afatinib—ERBB2—Desoximetasone—Triamcinolone—asthma	2.75e-05	0.00491	CbGdCrCtD
Afatinib—ERBB2—Triamcinolone—Prednisone—asthma	2.75e-05	0.0049	CbGdCrCtD
Afatinib—ERBB2—Triamcinolone—Prednisolone—asthma	2.68e-05	0.00479	CbGdCrCtD
Afatinib—ERBB2—Desoximetasone—Prednisone—asthma	2.61e-05	0.00466	CbGdCrCtD
Afatinib—ERBB2—Desoximetasone—Prednisolone—asthma	2.55e-05	0.00454	CbGdCrCtD
Afatinib—ERBB2—Levonorgestrel—Hydrocortisone—asthma	1.77e-05	0.00316	CbGdCrCtD
Afatinib—ABCB1—Metabolism—ALOX15—asthma	6.79e-06	4.33e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—STAT3—asthma	6.78e-06	4.32e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—EGFR—asthma	6.78e-06	4.32e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ADCY2—asthma	6.77e-06	4.31e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NOS3—asthma	6.76e-06	4.31e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL3—asthma	6.75e-06	4.3e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—BDKRB2—asthma	6.74e-06	4.29e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—RHOA—asthma	6.73e-06	4.28e-05	CbGpPWpGaD
Afatinib—LCK—Disease—PPP2CA—asthma	6.72e-06	4.28e-05	CbGpPWpGaD
Afatinib—LCK—Hemostasis—VEGFA—asthma	6.69e-06	4.26e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—EGFR—asthma	6.68e-06	4.25e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—PTEN—asthma	6.67e-06	4.25e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NOS3—asthma	6.66e-06	4.24e-05	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—PTEN—asthma	6.65e-06	4.23e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—CRP—asthma	6.64e-06	4.23e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL6R—asthma	6.62e-06	4.21e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—TLR4—asthma	6.61e-06	4.21e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-DRB1—asthma	6.6e-06	4.21e-05	CbGpPWpGaD
Afatinib—LCK—Disease—CCR5—asthma	6.6e-06	4.2e-05	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—EGFR—asthma	6.58e-06	4.19e-05	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—asthma	6.55e-06	4.17e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—LEP—asthma	6.52e-06	4.15e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ADCY2—asthma	6.52e-06	4.15e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—PDGFB—asthma	6.51e-06	4.15e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL3—asthma	6.5e-06	4.14e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—TGFB1—asthma	6.5e-06	4.14e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CHAT—asthma	6.48e-06	4.13e-05	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—IL6—asthma	6.47e-06	4.12e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GSTP1—asthma	6.44e-06	4.1e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL1B—asthma	6.43e-06	4.1e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—EGFR—asthma	6.42e-06	4.09e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL2—asthma	6.41e-06	4.08e-05	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—PTEN—asthma	6.41e-06	4.08e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—TGFB1—asthma	6.38e-06	4.07e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—TLR4—asthma	6.37e-06	4.06e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—KNG1—asthma	6.36e-06	4.05e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-DRB1—asthma	6.36e-06	4.05e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—HMOX1—asthma	6.35e-06	4.05e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—POMC—asthma	6.34e-06	4.04e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ITPR1—asthma	6.34e-06	4.04e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—ICAM1—asthma	6.34e-06	4.04e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—AGTR1—asthma	6.33e-06	4.03e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—TGFB1—asthma	6.29e-06	4e-05	CbGpPWpGaD
Afatinib—LCK—Disease—PDGFB—asthma	6.28e-06	4e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CAT—asthma	6.27e-06	3.99e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—EGFR—asthma	6.26e-06	3.99e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CCL2—asthma	6.21e-06	3.95e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL6R—asthma	6.19e-06	3.94e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CXCL10—asthma	6.18e-06	3.94e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—EGFR—asthma	6.17e-06	3.93e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—FN1—asthma	6.15e-06	3.92e-05	CbGpPWpGaD
Afatinib—LCK—Hemostasis—TGFB1—asthma	6.14e-06	3.91e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—KNG1—asthma	6.13e-06	3.91e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—ICAM1—asthma	6.11e-06	3.89e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—AGTR1—asthma	6.1e-06	3.88e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—TNF—asthma	6.07e-06	3.86e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NTRK1—asthma	6.07e-06	3.86e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—PTEN—asthma	6.03e-06	3.84e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ADRB2—asthma	6e-06	3.82e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CXCL8—asthma	6e-06	3.82e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CXCL10—asthma	5.96e-06	3.79e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GSTM1—asthma	5.92e-06	3.77e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PLA2G4A—asthma	5.92e-06	3.77e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CXCL8—asthma	5.91e-06	3.76e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NTRK1—asthma	5.85e-06	3.72e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—NOS2—asthma	5.8e-06	3.7e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ADRB2—asthma	5.78e-06	3.68e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ALOX5—asthma	5.78e-06	3.68e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IL2—asthma	5.73e-06	3.65e-05	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—IL6—asthma	5.73e-06	3.65e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—BCL2—asthma	5.7e-06	3.63e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ITPR1—asthma	5.68e-06	3.62e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL6R—asthma	5.65e-06	3.6e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IL2—asthma	5.64e-06	3.59e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IFNG—asthma	5.64e-06	3.59e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—POMC—asthma	5.6e-06	3.57e-05	CbGpPWpGaD
Afatinib—LCK—Disease—NOS2—asthma	5.59e-06	3.56e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—RHOA—asthma	5.59e-06	3.56e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CARM1—asthma	5.51e-06	3.51e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CCL2—asthma	5.48e-06	3.49e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ITPR1—asthma	5.47e-06	3.48e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL6R—asthma	5.47e-06	3.48e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PPP2CA—asthma	5.45e-06	3.47e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD4—asthma	5.45e-06	3.47e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL6R—asthma	5.45e-06	3.47e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—DCN—asthma	5.43e-06	3.46e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—MMP9—asthma	5.42e-06	3.45e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—EGFR—asthma	5.42e-06	3.45e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CD86—asthma	5.41e-06	3.44e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—STAT3—asthma	5.39e-06	3.43e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—PTEN—asthma	5.39e-06	3.43e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—EDN1—asthma	5.36e-06	3.42e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—MMP9—asthma	5.34e-06	3.4e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CCL5—asthma	5.32e-06	3.39e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—PTEN—asthma	5.31e-06	3.38e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PLA2G4A—asthma	5.3e-06	3.38e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ALDH2—asthma	5.28e-06	3.36e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CSF2—asthma	5.24e-06	3.34e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—IL6R—asthma	5.22e-06	3.32e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CD86—asthma	5.21e-06	3.32e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL6—asthma	5.21e-06	3.32e-05	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—EGFR—asthma	5.21e-06	3.32e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—EDN1—asthma	5.17e-06	3.29e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL6—asthma	5.13e-06	3.27e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCL5—asthma	5.13e-06	3.27e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—SERPINE1—asthma	5.12e-06	3.26e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PLA2G4A—asthma	5.11e-06	3.25e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—SMAD3—asthma	5.1e-06	3.25e-05	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—IL6—asthma	5.06e-06	3.22e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CSF2—asthma	5.05e-06	3.22e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL1B—asthma	5.03e-06	3.21e-05	CbGpPWpGaD
Afatinib—LCK—Disease—IL6R—asthma	5.03e-06	3.2e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GSTT1—asthma	5.02e-06	3.2e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL2—asthma	5.01e-06	3.19e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—RHOA—asthma	4.94e-06	3.15e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—IL6—asthma	4.94e-06	3.14e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—SMAD3—asthma	4.92e-06	3.13e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CXCL8—asthma	4.91e-06	3.13e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—EGFR—asthma	4.9e-06	3.12e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—IL6—asthma	4.9e-06	3.12e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—SERPINE1—asthma	4.89e-06	3.11e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NOS3—asthma	4.89e-06	3.11e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PPP2CA—asthma	4.88e-06	3.11e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—VEGFA—asthma	4.87e-06	3.1e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—BCL2—asthma	4.87e-06	3.1e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—STAT3—asthma	4.82e-06	3.07e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IFNG—asthma	4.82e-06	3.07e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—IL6—asthma	4.81e-06	3.06e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—VEGFA—asthma	4.8e-06	3.06e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CCR5—asthma	4.79e-06	3.05e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—STAT3—asthma	4.75e-06	3.03e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—IL6—asthma	4.74e-06	3.02e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL2RA—asthma	4.73e-06	3.01e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—PTEN—asthma	4.72e-06	3e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—RHOA—asthma	4.72e-06	3e-05	CbGpPWpGaD
Afatinib—LCK—Disease—SERPINE1—asthma	4.71e-06	3e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PPP2CA—asthma	4.71e-06	3e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—BCL2—asthma	4.69e-06	2.99e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL2—asthma	4.69e-06	2.99e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—C3—asthma	4.69e-06	2.98e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—NOS3—asthma	4.67e-06	2.97e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD4—asthma	4.66e-06	2.97e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IFNG—asthma	4.65e-06	2.96e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCR5—asthma	4.62e-06	2.94e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PDGFB—asthma	4.56e-06	2.9e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL2RA—asthma	4.55e-06	2.9e-05	CbGpPWpGaD
Afatinib—LCK—Disease—RHOA—asthma	4.54e-06	2.89e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—C3—asthma	4.52e-06	2.88e-05	CbGpPWpGaD
Afatinib—LCK—Disease—NOS3—asthma	4.5e-06	2.86e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—CD4—asthma	4.49e-06	2.86e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TGFB1—asthma	4.47e-06	2.85e-05	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—ALB—asthma	4.4e-06	2.8e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TGFB1—asthma	4.4e-06	2.8e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PDGFB—asthma	4.4e-06	2.8e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—EGFR—asthma	4.38e-06	2.79e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—LEP—asthma	4.36e-06	2.78e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CXCL8—asthma	4.34e-06	2.76e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—IL6—asthma	4.32e-06	2.75e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—EGFR—asthma	4.32e-06	2.75e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL1B—asthma	4.3e-06	2.74e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—CD4—asthma	4.3e-06	2.74e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL2—asthma	4.29e-06	2.73e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—PTGS2—asthma	4.27e-06	2.72e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—STAT3—asthma	4.22e-06	2.69e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—LEP—asthma	4.2e-06	2.68e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—POMC—asthma	4.18e-06	2.66e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—NQO1—asthma	4.18e-06	2.66e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—IL6—asthma	4.17e-06	2.65e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL1B—asthma	4.15e-06	2.64e-05	CbGpPWpGaD
Afatinib—LCK—Disease—CD4—asthma	4.14e-06	2.64e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL2—asthma	4.14e-06	2.64e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL2—asthma	4.13e-06	2.63e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—FN1—asthma	4.11e-06	2.62e-05	CbGpPWpGaD
Afatinib—LCK—Disease—PTGS2—asthma	4.11e-06	2.62e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ADCY2—asthma	4.09e-06	2.6e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—PTEN—asthma	4.03e-06	2.57e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—FN1—asthma	3.96e-06	2.52e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—MMP9—asthma	3.92e-06	2.5e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—PTEN—asthma	3.9e-06	2.48e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—PTEN—asthma	3.89e-06	2.47e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—EGFR—asthma	3.84e-06	2.44e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ALB—asthma	3.81e-06	2.43e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL6—asthma	3.77e-06	2.4e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—POMC—asthma	3.75e-06	2.39e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—PTEN—asthma	3.72e-06	2.37e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CCL2—asthma	3.67e-06	2.34e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL6R—asthma	3.66e-06	2.33e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—NOS3—asthma	3.65e-06	2.32e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—POMC—asthma	3.61e-06	2.3e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—STAT3—asthma	3.61e-06	2.3e-05	CbGpPWpGaD
Afatinib—LCK—Disease—PTEN—asthma	3.59e-06	2.28e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCL2—asthma	3.53e-06	2.25e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL6R—asthma	3.52e-06	2.24e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—VEGFA—asthma	3.52e-06	2.24e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—STAT3—asthma	3.49e-06	2.22e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GSTP1—asthma	3.48e-06	2.22e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—STAT3—asthma	3.47e-06	2.21e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—HMOX1—asthma	3.43e-06	2.19e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ITPR1—asthma	3.43e-06	2.18e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—SERPINE1—asthma	3.42e-06	2.18e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CAT—asthma	3.39e-06	2.16e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IL6—asthma	3.37e-06	2.15e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PTGS2—asthma	3.34e-06	2.13e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—STAT3—asthma	3.33e-06	2.12e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IL6—asthma	3.32e-06	2.11e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—RHOA—asthma	3.3e-06	2.1e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—SERPINE1—asthma	3.3e-06	2.1e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NOS3—asthma	3.27e-06	2.08e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TGFB1—asthma	3.23e-06	2.06e-05	CbGpPWpGaD
Afatinib—LCK—Disease—STAT3—asthma	3.21e-06	2.04e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PLA2G4A—asthma	3.2e-06	2.04e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GSTM1—asthma	3.2e-06	2.04e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—RHOA—asthma	3.18e-06	2.03e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—EGFR—asthma	3.17e-06	2.02e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—EGFR—asthma	3.16e-06	2.01e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NOS3—asthma	3.15e-06	2.01e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—TGFB1—asthma	3.09e-06	1.97e-05	CbGpPWpGaD
Afatinib—LCK—Disease—TGFB1—asthma	2.97e-06	1.89e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PPP2CA—asthma	2.95e-06	1.88e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL6—asthma	2.95e-06	1.88e-05	CbGpPWpGaD
Afatinib—LCK—Disease—EGFR—asthma	2.92e-06	1.86e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PTEN—asthma	2.91e-06	1.85e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CXCL8—asthma	2.9e-06	1.85e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CXCL8—asthma	2.79e-06	1.78e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL2—asthma	2.77e-06	1.76e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL6—asthma	2.76e-06	1.76e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL2—asthma	2.67e-06	1.7e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—MMP9—asthma	2.62e-06	1.67e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PTEN—asthma	2.61e-06	1.66e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—MMP9—asthma	2.53e-06	1.61e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL6—asthma	2.52e-06	1.6e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PTEN—asthma	2.51e-06	1.6e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL6—asthma	2.44e-06	1.55e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL6—asthma	2.43e-06	1.55e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—VEGFA—asthma	2.35e-06	1.5e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—STAT3—asthma	2.33e-06	1.48e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—IL6—asthma	2.33e-06	1.48e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—VEGFA—asthma	2.27e-06	1.45e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—POMC—asthma	2.26e-06	1.44e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—STAT3—asthma	2.25e-06	1.43e-05	CbGpPWpGaD
Afatinib—LCK—Disease—IL6—asthma	2.24e-06	1.43e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TGFB1—asthma	2.16e-06	1.38e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TGFB1—asthma	2.08e-06	1.33e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ALB—asthma	2.06e-06	1.31e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—EGFR—asthma	2.04e-06	1.3e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—NOS3—asthma	1.97e-06	1.26e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PTGS2—asthma	1.8e-06	1.15e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL6—asthma	1.63e-06	1.04e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PTEN—asthma	1.57e-06	1e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL6—asthma	1.57e-06	9.99e-06	CbGpPWpGaD
